Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment

The objectives of this study were to describe meropenem pharmacokinetics (PK) in plasma and/or subcutaneous adipose tissue (SCT) in critically ill patients receiving extracorporeal membrane oxygenation (ECMO) treatment and to develop a population PK model to simulate alternative dosing regimens and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Hanberg, Pelle, Öbrink-Hansen, Kristina, Thorsted, Anders, Bue, Mats, Tøttrup, Mikkel, Friberg, Lena E., Hardlei, Tore Forsingdal, Søballe, Kjeld, Gjedsted, Jakob
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2018
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5923145/
https://ncbi.nlm.nih.gov/pubmed/29530848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02390-17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires